Talk:Recombinant human epidermal growth factor

Latest comment: 8 years ago by Jytdog in topic Sources

POV Issues

edit

This article has some very major POV issues. Some examples to get other editors going:

  • This section is intended to make it seems like scientists in the USA are marginalizing the drug due to political issues, by attributing to the whole group a quote which is completely unattributed and cannot be used to represent the whole group, even if it were sourced to someone within said group: "The drug and clinical trials have been looked over by scientists in the USA, calling the drug "very clever", but the political situation..."

Unfortunately, I don't have the time right now or in the foreseeable future to draw up a better version, but I'll see what I can do. Aero-Plex (talk) 15:00, 20 December 2013 (UTC)Reply

As you diputed the neutrality of this source I assume you've read the entire article. Unfortunately you must have missed the part where the "clever" quote is even announced in a headline. De728631 (talk) 14:43, 19 October 2014 (UTC)Reply
And I have to admit that I missed the fact that "Heberprot" is not mentioned in there. Instead the drug discussed in the MSNBC article is called Citoprot-P. Maybe that was an early-stage name of the generic substance while Heberprot is a brand? De728631 (talk) 15:21, 19 October 2014 (UTC)Reply
The developer's "History" page quotes a peer-reviewed publication that refers to "Intralesional Injections of Citoprot-P..." so I guess that's it. But we need a source that draws a direct line between the two names. De728631 (talk) 15:55, 19 October 2014 (UTC)Reply
[omicsgroup.org/journals/medication-safety-in-hospitals-avoiding-medication-errors-in-the-medication%20use-process-2167-1052.1000134.pdf[predatory publisher] This] essay states that "The growth factor is ... a lyophilized preparation containing 25 or 75 μg of rhEGF per vial under the brand Heberprot P®." De728631 (talk) 18:58, 19 October 2014 (UTC)Reply
edit

Hello fellow Wikipedians,

I have just added archive links to one external link on Heberprot-P. Please take a moment to review my edit. If necessary, add {{cbignore}} after the link to keep me from modifying it. Alternatively, you can add {{nobots|deny=InternetArchiveBot}} to keep me off the page altogether. I made the following changes:

When you have finished reviewing my changes, please set the checked parameter below to true to let others know.

 Y An editor has reviewed this edit and fixed any errors that were found.

  • If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
  • If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—cyberbot IITalk to my owner:Online 11:40, 26 February 2016 (UTC)Reply

Sources

edit

OK.... so looking for Heberprot-P there are no reviews in Pubmed. There are 7 primary sources going back to 2009. Jytdog (talk) 08:08, 31 August 2016 (UTC)Reply

PMID 23396236 is a review but not indexed as such by pubmed. It is not independent (by the lab that developed it) but it is the best thing we have. Jytdog (talk) 08:45, 31 August 2016 (UTC)Reply
but the search with the generic name yields... 9! Jytdog (talk) 08:50, 31 August 2016 (UTC)Reply